FeesSafety
Pluang+

PVH struggles with brand image despite CEO's plan to boost direct sales and control licensing.

Analyst Insights
17 Nov 2026, 10:21 WIB
Seeking Alpha
View Source
Neutral
PVH struggles with brand image despite CEO's plan to boost direct sales and control licensing.

PVH Corp. faces challenges in improving its brand image due to heavy reliance on wholesale, outlet sales, and extensive licensing, which limit pricing power and quality control. CEO Stefan Larsson's PVH+ plan aims to enhance brand perception by expanding direct-to-consumer sales and regaining license control. However, progress has been limited as direct sales and margins have not significantly improved, and key brand elevation steps like reducing promotions and enhancing product quality remain unaddressed. Investors are advised to watch for improvements in direct sales mix, supply chain quality, pricing discipline, and working capital as indicators of a genuine turnaround.

PVH Corp.'s brand elevation efforts provide context for consumer cyclical sector performance on Pluang. For readers following this sector, here is the market snapshot as of Nov 17, 2026 15:41 WIB: out of 134 priced US stocks, 32 rose and 93 fell. Notable movers include GAP at USD 19.87 with a -5.70% change and 100% buy order activity, CAVA at USD 55.00 with a -5.55% change and 100% buy order activity, and JMIA at USD 5.04 with a -5.53% change and a typical hold time of 29 days.

More News

Bernstein SocGen downgrades PepsiCo to Underperform amid weak demand and rising costs

Bernstein SocGen downgrades PepsiCo to Underperform amid weak demand and rising costs

Bernstein SocGen Group downgraded PepsiCo's stock rating from Market Perform to Underperform due to weak North American demand, rising input costs, and margin pressures. PepsiCo's shares have fallen 2.4% over the past six months, underperforming its ...

Analyst Insights
Bearish
52 minutes ago
Atos secures contract to manage and unify France's shared medical records platform with Mon Espace Santé.

Atos secures contract to manage and unify France's shared medical records platform with Mon Espace Santé.

Atos has been selected by France's Caisse nationale de l’Assurance Maladie (Cnam) to manage and secure the Dossier Médical Partagé (DMP) and integrate it with Mon Espace Santé (MES) into a unified digital health platform. This platform, serving over ...

Market News
Bullish
53 minutes ago
Atos completes integration of France's Shared Medical Record with Mon Espace Santé platform

Atos completes integration of France's Shared Medical Record with Mon Espace Santé platform

Atos has successfully transitioned and integrated France's Shared Medical Record (DMP) with the Mon Espace Santé (MES) platform, creating a unified, secure digital health infrastructure for over 60 million insured people. This integration supports th...

Market News
Bullish
53 minutes ago
Commit Biologics raises $60M seed round to advance novel immune therapy for cancer and autoimmune diseases

Commit Biologics raises $60M seed round to advance novel immune therapy for cancer and autoimmune diseases

Commit Biologics secured $60 million in seed funding led by Ackermans & van Haaren with participation from AbbVie Ventures, M Ventures, and others. The funds will support clinical development of COM002, a first-in-class immune engager targeting cance...

Company Fundamentals
Bullish
3 hours ago
Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.

Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.

Dassault Systèmes announced at its 2026 Capital Markets Day a new growth cycle aiming for double-digit revenue and EPS growth by 2029, targeting over €8 billion in revenue and €1.80 in non-IFRS diluted EPS. The company highlights its transition to su...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App